Ergoteles’s Cerence CRNC Stock Holding History

Ergoteles’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-36,859	Closed	-$2.83M	–	1286
2021 Q4	$2.83M	Buy	+36,859	New	+$3.25M	0.11%	197
2021 Q3	–	Sell	-9,000	Closed	-$960K	–	1285
2021 Q2	$960K	Buy	+9,000	New	+$886K	0.02%	517

Other funds holding CRNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Ergoteles's CRNC Position: Q1 2022 in Review

Ergoteles sold out of Cerence (CRNC) in Q1 2022, closing a stake of 36,859 shares — an estimated $2.83M sold.

Ergoteles first reported a position in CRNC in Q2 2021 and held it in 2 quarters. The position peaked at $2.83M in Q4 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

Ergoteles reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
Ergoteles sold 36,859 Cerence shares in Q1 2022, an estimated $2.83M.
Ergoteles first reported a position in Cerence in Q2 2021 and held it in 2 quarters.
Ergoteles's Cerence position peaked at $2.83M in Q4 2021.
286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.